MCG Pharmaceuticals has reported some new data from preclinical laboratory studies done by its research collaborator, Slovenia's National Institute of Biology. The data highlights the possible use of cannabinoids in the treatment of glioblastoma multiforme (GBM), the aggressive, and most common, br
20 Jun 2022
Cannabinoids combat brain cancer cells
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Cannabinoids combat brain cancer cells
Argent Biopharma Ltd (RGT:ASX) | 0 0 0.0% | Mkt Cap: 113.7m
- Published:
20 Jun 2022 -
Author:
Robin Davison -
Pages:
4
MCG Pharmaceuticals has reported some new data from preclinical laboratory studies done by its research collaborator, Slovenia's National Institute of Biology. The data highlights the possible use of cannabinoids in the treatment of glioblastoma multiforme (GBM), the aggressive, and most common, br